GlassScriptPhysician profile
Roberto Prieto-Harris
NPI 1578777181
$554.12
in general payments reported to CMS, 2019-2025
11 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $54.62 · 2021: $16.43 · 2022: $65.76 · 2023: $26.81 · 2024: $110 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $158.84 | 2019-2024 | Summit Doppler |
| Exeltis, USA INC. | $73.21 | 2019-2023 | Slynd |
| Abbvie INC. | $59.96 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $50.26 | 2025 | Myfembree |
| Organon LLC | $49.23 | 2022-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $34.44 | 2019 | |
| Baxter Healthcare | $32.82 | 2025 | Perclot |
| Boston Scientific Corporation | $31.38 | 2020-2025 | Axonics |
| Davol INC. | $24.73 | 2024 | Arista Ah Flexitip |
| Evofem Biosciences, INC. | $22.17 | 2022 | |
| Agile Therapeutics, INC. | $17.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Prieto-Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.